Abstract
Background and Objectives Tremelimumab is a monoclonal human antibody that inhibits cytotoxic T-lymphocyte-associated antigen 4, giving rise to increa......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
